ReShape Lifesciences, Inc. (OTCQB: RSLS) develops minimally invasive medical devices that treat obesity and metabolic diseases. With groundbreaking products as the LAP-BAND Adjustable Gastric Banding, ReShape Lifesciences possesses twenty years of reported clinical efficacy. President & CEO, Barton P. Bandy, joins us in this episode to talk about the design and impact of the company’s products and its drive to reduce the cost burden associated with the treatment of obesity diseases.